Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial

American Heart Journal

Volumn 166, Issue 6, 2013, Pages

  Weisz, Giora ^a,b   Farzaneh Far, Ramin ^c   Ben Yehuda, Ori ^b   Debruyne, Bernard ^d   Montalescot, Gilles ^e   Lerman, Amir ^f   Mahmud, Ehtisham ^g   Alexander, Karen P ^h   Ohman, E Magnus ^h   White, Harvey D ⁱ   Olmsted, Ann ^c   Walker, Gennyne A ^c   Stone, Gregg W ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c GILEAD SCIENCES   (United States)

^d CARDIOVASCULAR CENTER   (Belgium)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h DUKE CLINICAL RESEARCH INSTITUTE   (United States)

ⁱ AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

RANOLAZINE; ACETANILIDE DERIVATIVE; ENZYME INHIBITOR; PIPERAZINE DERIVATIVE;

ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HOSPITALIZATION; HUMAN; INCOMPLETE REVASCULARIZATION; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SUDDEN CARDIAC DEATH; CLINICAL TRIAL; FEMALE; MALE; MULTICENTER STUDY; RETREATMENT; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ACETANILIDES; ANGINA PECTORIS; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; HOSPITALIZATION; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PIPERAZINES; QUALITY OF LIFE; RANOLAZINE; RETREATMENT; TREATMENT OUTCOME;

EID: 84888636467     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.08.004     Document Type: Article

References (42)

1. P.W. Serruys, F. Unger, and J.E. Sousa Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease N Engl J Med 344 2001 1117 1124
2. D.J. Cohen, B. Van Hout, and P.W. Serruys Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery N Engl J Med 364 2011 1016 1026
3. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
4. G.F. Rosner, A.J. Kirtane, and P. Genereux Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial Circulation 125 2012 2613 2620
5. A.J. Buda, I.L. Macdonald, and M.J. Anderson Long-term results following coronary bypass operation. Importance of preoperative actors and complete revascularization J Thorac Cardiovasc Surg 82 1981 383 390
6. T. Kleisli, W. Cheng, and M.J. Jacobs In the current era, complete revascularization improves survival after coronary artery bypass surgery J Thorac Cardiovasc Surg 129 2005 1283 1291
7. M.J. van den Brand, B.J. Rensing, and M.A. Morel The effect of completeness of revascularization on event-free survival at one year in the ARTS trial J Am Coll Cardiol 39 2002 559 564
8. E.L. Hannan, M. Racz, and D.R. Holmes Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era Circulation 113 2006 2406 2412
9. E.L. Hannan, C. Wu, and G. Walford Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes JACC Cardiovasc Interv 2 2009 17 25
10. S.W. Kirschbaum, T. Springeling, and E. Boersma Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging JACC Cardiovasc Interv 3 2010 392 400
11. C. Wu, A.M. Dyer, and S.B. King 3rd Impact of incomplete revascularization on long-term mortality after coronary stenting Circ Cardiovasc Interv 4 2011 413 421
12. E. Nikolsky, L. Gruberg, and C.V. Patil Percutaneous coronary interventions in diabetic patients: is complete revascularization important? J Invasive Cardiol 16 2004 102 106
13. C.S. McLellan, W.A. Ghali, and M. Labinaz Association between completeness of percutaneous coronary revascularization and postprocedure outcomes Am Heart J 150 2005 800 806
14. Z. Kalarus, R. Lenarczyk, and J. Kowalczyk Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention Am Heart J 153 2007 304 312
15. C. Tamburino, D.J. Angiolillo, and P. Capranzano Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents Catheter Cardiovasc Interv 72 2008 448 456
16. G.B. Mancini, E.R. Bates, and D.J. Maron Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial Circ Cardiovasc Qual Outcomes 2 2009 320 327
17. E. Meliga, C. Fiorina, and M. Valgimigli Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease J Interv Cardiol 24 2011 535 541
18. F. Hussain, R.K. Philipp, and R.A. Ducas The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators Catheter Cardiovasc Interv 78 2011 540 548
19. R.D. Vieira, W. Hueb, and B.J. Gersh Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial Circulation 126 2012 S158 S163
20. J.W. Chung, K.H. Park, and M.H. Lee Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era Circ J 76 2012 1624 1630
21. J.A. Suero, S.P. Marso, and P.G. Jones Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience J Am Coll Cardiol 38 2001 409 414
22. Z. Olivari, P. Rubartelli, and F. Piscione Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE) J Am Coll Cardiol 41 2003 1672 1678
23. A. Hoye, R.T. van Domburg, and K. Sonnenschein Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002 Eur Heart J 26 2005 2630 2636
24. J.A. Grantham, P.G. Jones, and L. Cannon Quantifying the early health status benefits of successful chronic total occlusion recanalization: results from the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial Circ Cardiovasc Qual Outcomes 3 2010 284 290
25. D. Joyal, J. Afilalo, and S. Rinfret Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis Am Heart J 160 2010 179 187
26. R. Mehran, B.E. Claessen, and C. Godino Long-term outcome of percutaneous coronary intervention for chronic total occlusions JACC Cardiovasc Interv 4 2011 952 961
27. J.A. McPherson, A. Maehara, and G. Weisz Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention JACC Cardiovasc Imaging 5 2012 S76 S85
28. S.J. Head, M.J. Mack, and D.R. Holmes Jr. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data Eur J Cardiothorac Surg 41 2012 535 541
29. G. Rosner, P. Green, and A.J. Kirtane Relationship between reference vessel diameter and the incidence and impact of incomplete coronary revascularization following PCI in ACS: the ACUITY trial J Am Coll Cardiol 60 2012 B137
30. H. Fraser, L. Belardinelli, and L. Wang Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts J Mol Cell Cardiol 41 2006 1031 1038
31. L. Belardinelli, J.C. Shryock, and H. Fraser Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine Heart 92 Suppl. 4 2006 iv6 iv14
32. B.R. Chaitman, S.L. Skettino, and J.O. Parker Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina J Am Coll Cardiol 43 2004 1375 1382
33. B.R. Chaitman, C.J. Pepine, and J.O. Parker Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial JAMA 291 2004 309 316
34. P.H. Stone, N.A. Gratsiansky, and A. Blokhin Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial J Am Coll Cardiol 48 2006 566 575
35. D.A. Morrow, B.M. Scirica, and E. Karwatowska-Prokopczuk Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA 297 2007 1775 1783
36. S.R. Wilson, B.M. Scirica, and E. Braunwald Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 trial J Am Coll Cardiol 53 2009 1510 1516
37. B. Scirica, B. Murphy, and E. Karwatowska-Prokopczuk Effects of ranolazine in patients with ACS and stable angina according to whether they undergo PCI: observations from MERLIN-TIMI 36 trial J Am Coll Cardiol 60 2012 B210
38. J.A. Spertus, J.A. Winder, and T.A. Dewhurst Monitoring the quality of life in patients with coronary artery disease Am J Cardiol 74 1994 1240 1244
39. D. Mozaffarian, C.L. Bryson, and J.A. Spertus Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease Am Heart J 146 2003 1015 1022
40. J. Alonso, G. Permanyer-Miralda, and P. Cascant Measuring functional status of chronic coronary patients. Reliability, validity and responsiveness to clinical change of the reduced version of the Duke Activity Status Index (DASI) Eur Heart J 18 1997 414 419
41. P. Dolan Modeling valuations for EuroQol health states Med Care 35 1997 1095 1108
42. M.C. Weinstein, and W.B. Stason Foundations of cost-effectiveness analysis for health and medical practices N Engl J Med 296 1977 716 721